Sequenom, Inc. (SQNM) Posts Q2 EPS Loss of $0.21, Sales Fall Short
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts SQNM Hot Sheet
Price: $2.39 --0%
Financial Fact:
Genetic analysis product sales and services: 2.78M
Today's EPS Names:
AEHR, VFS, CMTL, More
Financial Fact:
Genetic analysis product sales and services: 2.78M
Today's EPS Names:
AEHR, VFS, CMTL, More
Join SI Premium – FREE
Sequenom, Inc. (NASDAQ: SQNM) reported Q2 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $13.3 million versus the consensus estimate of $13.78 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Levi (LEVI) Tops Q3 EPS by 12c; raises guidance
- Apogee Enterprises (APOG) Tops Q2 EPS by 54c ; Offers Guidance
- Neogen Corp. (NEOG) Tops Q1 EPS by 3c; raises guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
